Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IRAK4 | Q9NWZ3 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.38 |
| ▸ | CCR1 | P32246 | 1/20 | 0.36 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.32 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.32 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.32 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.32 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.32 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20436438 | 0.81 | TSHR (0.37) | IRAK4CCR1KCNH2 | |
| SCHEMBL20416692 | 0.81 | CCR1 (0.39) | IRAK4HSD11B1CCR1 | |
| SCHEMBL1579296 | 0.81 | HTT (0.42) | LMNAHSD11B1CCR1ADRB1 | |
| SCHEMBL4047127 | 0.79 | GABRA1 (0.42) | IRAK4CCR1 | |
| SCHEMBL20442084 | 0.77 | IRAK4 (0.33) | IRAK4CCR1KCNH2 | |
| SCHEMBL20416948 | 0.77 | KDM4E (0.35) | LMNAHSD11B1ADRB1HRH4GRIN2D | |
| SCHEMBL19085083 | 0.77 | CCR1 (0.39) | IRAK4CCR1 | |
| SCHEMBL20400486 | 0.76 | CCR1 (0.38) | IRAK4CCR1 | |
| SCHEMBL17559548 | 0.76 | NOS3 (0.42) | LMNAHSD11B1ADRB1 | |
| SCHEMBL21010067 | 0.76 | IRAK4 (0.42) | IRAK4LMNAHSD11B1ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136251-B2 | Compositions, methods, and devices for capturing phosphate from water | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2021-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11136251-B2 | Compositions, methods, and devices for capturing phosphate from water | PPA1, ACP3, CASR | IRAK4 2837/4885LMNA 3172/4885HSD11B1 4736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.